Cash and Short Term Investments (Quarterly) Chart

View Cash and Short Term Investments (Quarterly) for PSNL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Quarterly) Chart
Start Trial

Historical Cash and Short Term Investments (Quarterly) Data

View and export this data back to 2018. Start Trial.
Date Value
June 30, 2026 212.66M
March 31, 2026 233.22M
December 31, 2025 239.95M
September 30, 2025 150.52M
June 30, 2025 173.23M
March 31, 2025 185.69M
December 31, 2024 185.01M
September 30, 2024 143.65M
June 30, 2024 86.97M
March 31, 2024 95.42M
December 31, 2023 114.18M
September 30, 2023 120.66M
June 30, 2023 137.21M
March 31, 2023 148.94M
December 31, 2022 167.66M
September 30, 2022 192.76M
Date Value
June 30, 2022 233.49M
March 31, 2022 266.54M
December 31, 2021 287.06M
September 30, 2021 305.23M
June 30, 2021 328.91M
March 31, 2021 353.43M
December 31, 2020 203.29M
September 30, 2020 206.06M
June 30, 2020 105.23M
March 31, 2020 120.03M
December 31, 2019 128.29M
September 30, 2019 127.28M
June 30, 2019 163.27M
March 31, 2019 33.24M
December 31, 2018 19.74M

Cash and Short Term Investments Definition

Represents the sum of cash and short term investments.

Read full definition.

Cash and Short Term Investments (Quarterly) Range, Past 5 Years

View Cash and Short Term Investments (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Quarterly) Benchmarks

View Cash and Short Term Investments (Quarterly) Benchmarks
Start Trial
Tempus AI, Inc. 815.99M
10X Genomics, Inc. 552.03M
Alamar Biosciences, Inc. (California) 250.05M
Adaptive Biotechnologies Corp. 344.26M
Champions Oncology, Inc. 4.872M